Debra Ainge
Chief Executive Officer chez Iethico Ltd.
Profil
Debra Ainge is currently the Chief Executive Officer at Iethico Ltd.
and also serves as a Non-Executive Director at Pleco Therapeutics BV.
Previously, she worked as the Chief Operating Officer at Clinigen Ltd.
Dr. Ainge holds a doctorate degree from The University of Newcastle and the University of Lausanne.
Postes actifs de Debra Ainge
| Sociétés | Poste | Début |
|---|---|---|
Pleco Therapeutics BV
 Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Director/Board Member | - |
Iethico Ltd.
 Iethico Ltd. Information Technology ServicesTechnology Services Iethico Ltd. is a British company that aims to reduce the impact of medicine shortages and provide faster access to medicine. The company is based in Coventry, UK. The company links pharmacists to suppliers to bridge the gap between medicine access and supply. The company delivers insights to minimize medicine shortage impact through AI. The company was founded in 2021 by Renee Kalia, Claudio Zurzica. Debra Ainge has been the CEO of the company since 2020. | Chief Executive Officer | 01/09/2020 |
Anciens postes connus de Debra Ainge
| Sociétés | Poste | Fin |
|---|---|---|
| CLINIGEN GROUP PLC | Chief Operating Officer | - |
Formation de Debra Ainge
| The University of Newcastle | Doctorate Degree |
| University of Lausanne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom. | Commercial Services |
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Iethico Ltd. is a British company that aims to reduce the impact of medicine shortages and provide faster access to medicine. The company is based in Coventry, UK. The company links pharmacists to suppliers to bridge the gap between medicine access and supply. The company delivers insights to minimize medicine shortage impact through AI. The company was founded in 2021 by Renee Kalia, Claudio Zurzica. Debra Ainge has been the CEO of the company since 2020. | Technology Services |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Commercial Services |
